| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |